283 results on '"Ennishi, Daisuke"'
Search Results
2. Chimeric antigen receptor T-cell therapy after COVID-19 in refractory high-grade B-cell lymphoma
3. Endoscopic manifestation of intestinal transplant-associated microangiopathy after stem cell transplantation
4. Japanese phase Ib study of the oral PI3K-δ and -γ inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma
5. Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study
6. Topical application of activator protein-1 inhibitor T-5224 suppresses inflammation and improves skin barrier function in a murine atopic dermatitis-like dermatitis
7. Long-term outcomes of patients with primary intestinal follicular lymphoma managed with watch-and-wait strategy
8. Association between early corticosteroid administration and long-term survival in non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation
9. Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study
10. Biological and clinical significance of epigenetic alterations in B-cell lymphomas
11. Zandelisib (ME-401) in Japanese patients with relapsed or refractory indolent non-Hodgkin’s lymphoma: an open-label, multicenter, dose-escalation phase 1 study
12. Chronic active Epstein–Barr virus infection presenting as refractory chronic sinusitis
13. Higher incidence of thrombocytopenia during obinutuzumab plus bendamustine therapy for untreated follicular lymphoma: a retrospective analysis by the Okayama Hematology Study Group
14. Successful neutrophil engraftment supported by granulocyte transfusion in adult allogeneic transplant patients with peri-transplant active infection
15. Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma
16. Combination of reduced post‐transplant cyclophosphamide and early tacrolimus initiation increases the incidence of chronic graft‐versus‐host disease in human leukocyte antigen‐haploidentical peripheral blood stem‐cell transplantation
17. Recent updates on treatment options for primary follicular lymphoma of the gastrointestinal tract.
18. Transformation to diffuse large B-cell lymphoma with germinal center B-cell like subtype and discordant light chain expression in a patient with Waldenström macroglobulinemia/lymphoplasmacytic lymphoma
19. CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas
20. Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease
21. Negative Prognostic Impact of High-Dose or Long-Term Corticosteroid Use in Patients with Relapsed or Refractory B-Cell Lymphoma Who Received Tisagenlecleucel
22. The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan
23. Collection efficiency and safety of large‐volume leukapheresis for the manufacturing of tisagenlecleucel.
24. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial
25. Allogeneic hematopoietic stem cell transplantation in a prior lung transplant recipient
26. Treatment outcomes of IgG4-producing marginal zone B-cell lymphoma: a retrospective case series
27. Reduced dose of PTCy followed by adjuvant α-galactosylceramide enhances GVL effect without sacrificing GVHD suppression
28. Author Correction: 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy
29. Retroperitoneal leiomyosarcoma in a female patient with a germline splicing variant RAD51D c.904-2A > T: a case report
30. TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma
31. Persistent hypogammaglobulinemia due to immunoglobulin class switch impairment by peri-transplant rituximab therapy
32. Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab
33. Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma
34. A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence.
35. 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy
36. Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin–specific clinical impact
37. Evaluating the efficiency and safety of large‐volume leukapheresis using the Spectra Optia continuous mononuclear cell collection protocol for peripheral blood stem cell collection from healthy donors: A retrospective study.
38. Correction to: The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan
39. Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL
40. Cell of origin of transformed follicular lymphoma
41. Feasibility of flow cytometric analysis of restricted light chain in endoscopic biopsy specimens from patients with gastrointestinal tract B cell lymphoma: a pilot study
42. Long non‐coding RNAs associated with transcriptomic signatures and treatment outcome in diffuse large B‐cell lymphoma.
43. Bone marrow microenvironment disruption and sustained inflammation with prolonged haematologic toxicity after CAR T‐cell therapy.
44. Efficient granulocyte collection method using high concentrations of medium molecular weight hydroxyethyl starch.
45. Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma
46. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
47. Early initiation of low-dose gilteritinib maintenance improves posttransplant outcomes in patients with R/R FLT3mut AML
48. Clinical Impact of Cell-of-Origin and Double-Hit Signature of DLBCL in Japan
49. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development
50. Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.